How much is Evommune worth in 2026?

Evommune has a current valuation of N/A based on their Later Stage VC (Series C) round and secondary market data.

How much funding has Evommune raised?

Evommune has raised N/A in total funding across 1 funding rounds.

Evommune

Drug Discovery

Evommune valuation and funding history | Last updated: October 30, 2024 | 1 funding rounds

Current Valuation

N/A

As of October 30, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series C)

$115.5M

Last Funding

Oct 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 30, 2024	Later Stage VC (Series C)	$115.5M	N/A	-

Valuation Analysis

Current Valuation Metrics

Evommune is currently valued at N/A as of October 30, 2024.

Track Evommune Valuation Updates

Get notified when Evommune raises new funding or valuation changes

Explore More Data

Detailed analysis for Evommune

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Evommune's valuation history, funding rounds, and growth metrics.

No credit card required

What is Evommune Worth in 2026?

Evommune is a leading private company in the Drug Discovery sector. Track Evommune's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Evommune Valuation is Determined

Private company valuations like Evommune's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.